Results 151 to 160 of about 185,935 (339)

Outcomes of total hip arthroplasty in obese patients with and without preoperative weight loss: A systematic review and meta‐analysis

Journal of Experimental Orthopaedics, Volume 13, Issue 1, January 2026.
Abstract Purpose Obesity is often considered a relative contraindication to total hip arthroplasty (THA) due to presumed increased perioperative and postoperative risk. Consequently, obese patients are often advised to lose weight prior to THA. However, the effect of preoperative weight loss on THA outcomes remains uncertain.
Nils Meissner, Sonia Ramos‐Pascual, Katharina Ortwig, Floris van Rooij, Daniel Schrednitzki, Johannes Stoeve, Andreas M. Halder   +6 more
wiley   +1 more source

Concurrent Mesh Repair of a Morgagni and Umbilical Hernia during a Laparoscopic Sleeve Gastrectomy in a Morbidly Obese Individual [PDF]

Journal of Krishna Institute of Medical Sciences University, 2016
Morgagni Hernia is a rare form of diaphragmatic hernia. It is mainly asymptomatic and often identified incidentally during surgery. Tension-free synthetic mesh repair is the preferred treatment modality.
N.R Kosai, R. Reynu, H.S Gendeh, Srijit Das, M. Lakdawala   +4 more
doaj  

Seven-year trajectories of body weight, quality of life and comorbidities following Roux-en-Y gastric bypass and sleeve gastrectomy [PDF]

, 2022
Hans Jørgen Nielsen, Bjørn Gunnar Nedrebø, Alexander Fosså, John Roger Andersen, Jörg Aßmus, Vigdis Halvorsen Dagsland, Simon N. Dankel, Oddrun Anita Gudbrandsen, Johan Fernø, Iren D. Hjellestad, Marianne Jensen Hjermstad, Ronette L. Kolotkin, Håvard Luong Thorsen, Gunnar Mellgren, Tone Nygaard Flølo   +14 more
openalex   +1 more source

Roux-Y Gastric Bypass and Sleeve Gastrectomy directly change gut microbiota composition independent of surgery type

Scientific Reports, 2019
Bariatric surgery in morbid obesity, either through sleeve gastrectomy (SG) or Roux-Y gastric bypass (RYGB), leads to sustainable weight loss, improvement of metabolic disorders and changes in intestinal microbiota.
F. Paganelli, M. Luyer, C. Hazelbag, H. Uh, Malbert R. C. Rogers, D. Adriaans, Roos-Marijn Berbers, Antoni P. A. Hendrickx, Marco C. Viveen, James A. Groot, M. Bonten, A. C. Fluit, Rob J. L. Willems, H. Leavis   +13 more
semanticscholar   +1 more source

Effect of Zoledronic Acid on Skeletal Muscle After Bariatric Surgery: A Secondary Analysis From a Randomized Controlled Trial

Obesity, Volume 34, Issue 1, Page 76-87, January 2026.
ABSTRACT Objective This study aimed to investigate whether a single infusion of 5 mg zoledronic acid, given before bariatric surgery to prevent bone loss, could also hinder the loss of muscle mass, strength, and physical function. Methods In this double‐blinded study, patients referred for bariatric surgery were randomized 1:1 to either intervention ...
Søren Gam, Anne Pernille Hermann, Claus Bogh Juhl, Stinus Gadegaard Hansen, Bibi Gram   +4 more
wiley   +1 more source

Chirurgie bariatrique en 2013: principes, avantages et inconvénients des interventions a disposition [Bariatric surgery in 2013: principles, advantages and disadvantages of the available procedures]. [PDF]

, 2013
For severe obesity (BMI > 35 kg/m2), bariatric surgery is not only the best, but often the only means of obtaining sufficient and durable weight loss. This article aims to review the available bariatric procedures. Gastric bypass remains the reference
Giusti, V., Suter, M.
core  

Systematic Review: Efficacy, Safety and Metabolic Outcomes of GLP‐1 Receptor Agonists in Inflammatory Bowel Disease

Alimentary Pharmacology &Therapeutics, Volume 63, Issue 1, Page 17-39, January 2026.
GLP‐1 receptor agonists are generally effective in weight loss and improvement in metabolic markers. They are well tolerated in patients with inflammatory bowel disease, with observational evidence showing no increased risk of disease exacerbation and possible signals of reduced steroid use, hospitalization, and surgery. ABSTRACT Background Obesity and
Brooke Maracle, Steven Quan, Patrick Hamilton, Asma Shaikh, Deepan Hazra, Diane L. Lorenzetti, Stephanie L. Gold, Maitreyi Raman, Joëlle St‐Pierre   +8 more
wiley   +1 more source

Factors Related to Weight Gain in Subjects with Sleeve Gastrectomy During Lockdown by the COVID-19 Pandemic [PDF]

, 2021
Daniel Antonio de Luis, Olatz Izaola, David Primo, Emilia Gómez Hoyos, Beatriz Torres, Juan José López Gómez, David Pacheco   +6 more
openalex   +1 more source

Sleeve Gastrectomy: Literature Results

Maedica - A Journal of Clinical Medicine
Sleeve gastrectomy (SG) is the most frequently performed bariatric procedure globally. However, data regarding short- and long-term results remain insufficient. This study aimed to evaluate the short- and longterm effects of SG. We performed a thorough PubMed search for references that mentioned sleeve gastrectomy was carried out.
Silvana, Leanza, Danilo, Coco, Massimo Giuseppee, Viola   +2 more
openaire   +2 more sources

Impact of Semaglutide on fat mass, lean mass and muscle function in patients with obesity: The SEMALEAN study

Diabetes, Obesity and Metabolism, Volume 28, Issue 1, Page 112-121, January 2026.
Abstract Aims Semaglutide, a GLP‐1 receptor agonist, has shown efficacy in promoting weight loss. However, limited data exist on its impact on lean mass, muscle function, and metabolic adaptations. The SEMALEAN study aims to evaluate these parameters in patients with obesity treated with Semaglutide (2.4 mg).
Mathieu Alissou, Thomas Demangeat, Vanessa Folope, Hélène Van Elslande, Hélène Lelandais, Julia Blanchemaison, Pierre‐Emmanuel Cailleaux, Suzan Guney, Alexandra Aupetit, Agnès Aubourg, Clément Rapp, André Petit, Morgane Godin, Luc Vignal, Sébastien Grigioni, Pierre Déchelotte, Guillaume Colange, Moïse Coëffier, Najate Achamrah   +18 more
wiley   +1 more source